CAS 1380723-44-3: Atezolizumab
Formula:Unspecified
- Synonyms:
- Immunoglobulin G1, anti-(human programmed death-1 ligand-1) (human monoclonal MPDL3280A heavy chain), disulfide with human monoclonal MPDL3280A κ-chain, dimer
- Atezolizumab
- Immunoglobulin G1, anti-(human CD antigen CD274) (human monoclonal MPDL3280A heavy chain), disulfide with human monoclonal MPDL3280A κ-chain, dimer
- MPDL 3280A
- RG 7446
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Atezolizumab REF: IN-DA01E6NDCAS: 1380723-44-3 | 99% | To inquire | Tue 04 Mar 25 |
 | Atezolizumab REF: TM-T9902CAS: 1380723-44-3 | 95.10% - 99.3% （SEC-HPLC） | 217.00 €~757.00 € | Tue 11 Mar 25 |
 | Atezolizumab REF: 3D-BA165584CAS: 1380723-44-3 | Min. 95% | 968.00 € | Thu 13 Mar 25 |
Ref: IN-DA01E6ND
| 1mg | 122.00 € | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 4 Mar 2025
Atezolizumab
CAS:1380723-44-3
Atezolizumab is an antibody inhibitor, a humanized monoclonal antibody, IgG1, which targets PD-L1. Atezolizumab has …
Purity:
95.10% - 99.3% （SEC-HPLC）
Color and Shape:
Liquid
Molecular weight:
145 kDa
Ref: TM-T9902
| 1mg | 217.00 € | ||
| 5mg | 515.00 € | ||
| 10mg | 757.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
Atezolizumab
CAS:1380723-44-3
Monoclonal antibody against PDL-1; anti-cancer agent
Purity:
Min. 95%
Color and Shape:
Clear Liquid
Ref: 3D-BA165584
| 1mg | 968.00 € |
Estimated delivery in United States, on Thursday 13 Mar 2025
